What is Joint Active Systems?
Joint Active Systems specializes in advanced range of motion devices and therapeutic solutions designed for patients experiencing upper extremity conditions and limited mobility. Their product portfolio includes dynamic and static progressive stretch braces for critical joints such as the shoulders, knees, and elbows. The company targets healthcare professionals, patients, and insurance adjusters, aiming to improve functional recovery and enhance the overall quality of life through clinically supported solutions. JAS is committed to precise measurement and customization to elevate user satisfaction and optimize patient outcomes.
How much funding has Joint Active Systems raised?
Joint Active Systems has raised a total of $2.1M across 2 funding rounds:
Debt
$1M
Debt
$1.1M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.1M led by PPP
Key Investors in Joint Active Systems
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Joint Active Systems?
The substantial enterprise-level funding, particularly the recent major strategic investment, positions Joint Active Systems for accelerated growth and market expansion. This capital infusion is likely to fuel further research and development into innovative therapeutic solutions, enhance manufacturing capabilities, and broaden their distribution network. The company's focus on improving patient outcomes and functional recovery through advanced bracing technology suggests a strategic direction towards solidifying its market leadership in the rehabilitation and medical device sector. Future endeavors may include expanding their product line, forging new clinical partnerships, and increasing their global footprint.
See full Joint Active Systems company page
